Development of Pasteurella multocida-loaded microparticles for hemorrhagic septicemia vaccine

被引:8
作者
Nimtrakul, Pataranapa [1 ,2 ]
Atthi, Ratchanee [3 ]
Limpeanchob, Nanteetip [4 ]
Tiyaboonchai, Waree [1 ,2 ]
机构
[1] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Phitsanulok 65000, Thailand
[2] Commiss Higher Educ, Ctr Excellence Innovat Chem, Bangkok, Thailand
[3] Bur Vet Biol, Dept Livestock Dev, Pakchong, Nakhonratchasim, Thailand
[4] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok 65000, Thailand
关键词
Alginate; hemorrhagic septicemia; microparticles; Pasteurella multocida; vaccine; ORAL VACCINATION; IMMUNE-RESPONSE; PARTICULATE VACCINES; PARTICLE-SIZE; IN-SITU; ALGINATE; MICROSPHERES; CALVES; PROTECTION; PATHOGEN;
D O I
10.3109/03639045.2013.873448
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, Pasteurella multocida-loaded alginate microparticles (MPs) for subcutaneous vaccination was developed by emulsification-cross-linking technique. Formulation parameter was varied as a ratio of polymer and bacterin. Optical microscopy revealed spherical particles with uniformly distribution. A mean particle size of approximately 6 mm has been successfully constructed using simple mixer and ultrasonic probe. The zeta potential of the MPs showed negatively charge of approximately -23mV determined by Zeta Pals (R) analyzer. The entrapment efficiency and the in vitro bacterin released profile could be controlled by varying the amount of alginate. The high entrapment efficiency up to 69% was achieved with low concentration of alginate. The MPs possessed a slow bacterin release profile, up to 30 days. In vivo safety and potency tests were proved that the alginate MPs were safe and induced protective immunity in mice. In addition, after storage for 6 months at either 4 degrees C or room temperature, the protective immunity in mice was maintained.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 33 条
[21]   Production and characterisation of alginate microparticles incorporating Aeromonas hydrophila designed for fish oral vaccination [J].
Rodrigues, AP ;
Hirsch, D ;
Figueiredo, HCP ;
Logato, PVR ;
Moraes, AM .
PROCESS BIOCHEMISTRY, 2006, 41 (03) :638-643
[22]  
Shah NH, 1997, FEMS MICROBIOL LETT, V155, P203, DOI 10.1111/j.1574-6968.1997.tb13879.x
[23]  
Sotoodehnia A., 2005, Archives of Razi Institute, P95
[24]   Immunization of rabbits against a bacterial pathogen with an alginate microparticle vaccine [J].
Suckow, MA ;
Jarvinen, LZ ;
HogenEsch, H ;
Park, K ;
Bowersock, TL .
JOURNAL OF CONTROLLED RELEASE, 2002, 85 (1-3) :227-235
[25]   Particle Size Influences the Immune Response Produced by Hepatitis B Vaccine Formulated in Inhalable Particles [J].
Thomas, Chandan ;
Gupta, Vivek ;
Ahsan, Fakhrul .
PHARMACEUTICAL RESEARCH, 2010, 27 (05) :905-919
[26]  
Tiyaboonchai W, 2010, NARESUAN U J, V18, P19
[27]   Alginate in drug delivery systems [J].
Tonnesen, HH ;
Karlsen, J .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (06) :621-630
[28]   Protection, humoral and cell-mediated immune responses in calves immunized with multiple emulsion haemorrhagic septicaemia vaccine [J].
Verma, R ;
Jaiswal, TN .
VACCINE, 1997, 15 (11) :1254-1260
[29]  
Watson F. M., 1998, COLLOID SURF A, V140, P53
[30]   Vaccine Adjuvants: Current Challenges and Future Approaches [J].
Wilson-Welder, Jennifer H. ;
Torres, Maria P. ;
Kipper, Matt J. ;
Mallapragada, Surya K. ;
Wannemuehler, Michael J. ;
Narasimhan, Balaji .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (04) :1278-1316